Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone and methylnaltrexone during exercise-induced breathlessness in COPD
ACTRN12611001182987Phase 3Recruiting
- Sponsor
- Flinders University
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naloxone, methylnaltrexone and Normal Saline-Benha University in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Flinders University. Primary endpoints: Intensity of dyspnea and Unpleasantness of dyspnea. Started Nov 2011; status: recruiting.
02
Drugs
naloxonemethylnaltrexoneNormal Saline-Benha University
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12611001182987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001182987.